8-K: Phreesia Acquires AccessOne, Reports First Net Income Positive Quarter

Phreesia announced its first net income positive quarter and a definitive agreement to acquire AccessOne for $160 million, expanding its healthcare payment solutions.

Summary

• Phreesia reported total revenue of $117.3 million for Q2 Fiscal 2026, a 15% year-over-year increase.
• Achieved net income of $0.7 million for the quarter, marking its first-ever net income positive quarter, compared to a net loss of $18.0 million in the prior year.
• Adjusted EBITDA significantly increased to $22.1 million, up from $6.5 million in the same period last year.
• Generated $14.8 million in net cash from operating activities and $9.6 million in free cash flow for the quarter.
• Entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. for $160 million in cash, expected to close in Q3 or early Q4 Fiscal 2026.
• The AccessOne acquisition is anticipated to contribute approximately $35 million in annualized revenue and $11 million in annualized Adjusted EBITDA, expanding Phreesia's addressable market by roughly $6 billion.
• Maintained fiscal 2026 revenue outlook of $472 million to $482 million (excluding AccessOne) and updated Adjusted EBITDA outlook to $87 million to $92 million (up from $85-$90 million, excluding AccessOne).
• Average number of healthcare services clients (AHSCs) grew 7% year-over-year to 4,467, with total revenue per AHSC increasing 7% year-over-year to $26,249.
• Introduced new AI-powered products: VoiceAI for call management, AI-Assisted Referrals for improved processing, and Out-of-Network Tags for insurance validation.

Sentiment

Score: 9

Explanation: The company achieved a significant milestone with its first net income positive quarter, coupled with strong growth in Adjusted EBITDA and free cash flow. The strategic acquisition of AccessOne is expected to expand its market and contribute positively to future financials. The updated Adjusted EBITDA outlook is also a positive indicator.

Positives

• Achieved first-ever net income positive quarter with $0.7 million, a significant improvement from a $18.0 million net loss year-over-year.
• Adjusted EBITDA surged to $22.1 million, a substantial increase from $6.5 million in the prior year, demonstrating strong operating leverage.
• Strong cash generation with $14.8 million in net cash from operating activities and $9.6 million in free cash flow.
• Strategic acquisition of AccessOne expands payment solutions, addresses a critical market gap, and is expected to add $35 million in annualized revenue and $11 million in annualized Adjusted EBITDA.
• The AccessOne acquisition is projected to expand the total addressable market by approximately $6 billion.
• Fiscal 2026 Adjusted EBITDA outlook was raised to $87 million to $92 million, indicating confidence in continued efficiency improvements.
• Consistent growth in Average Healthcare Services Clients (AHSCs) by 7% year-over-year to 4,467 and total revenue per AHSC by 7% year-over-year to $26,249.
• Strong revenue growth across all segments: network solutions up 25%, payment processing fees up 12%, and subscription and related services up 10% year-over-year.
• Successful product innovations including Phreesia VoiceAI, AI-Assisted Referrals, and Out-of-Network Tags, enhancing operational efficiency and patient experience.
• Cash and cash equivalents increased to $98.3 million, providing financial flexibility for future growth.

Negatives

• The take rate percentage for payment processing decreased slightly year-over-year from 2.9% to 2.8%.
• The fiscal 2026 revenue outlook of $472 million to $482 million and Adjusted EBITDA outlook of $87 million to $92 million exclude any additional revenue or impact from the AccessOne Acquisition, which could lead to underestimation if the acquisition closes as expected.
• The company expects to incur expenses associated with the AccessOne transaction, which will impact financial reporting.
• The merger agreement mentions "RK Matters" and "UCC Corrective Actions" as "Indemnified Liabilities" or actions to be completed, suggesting past or ongoing issues that required remediation or indemnification.

Risks

• Ability to effectively manage growth and meet growth objectives.
• Challenges in timely consummation of the AccessOne Acquisition, including securing required consents and regulatory approvals.
• Difficulty in obtaining funding for the AccessOne Acquisition.
• Risks associated with integrating AccessOne's operations and realizing anticipated operational or corporate synergies and other benefits.
• The competitive environment in which the company operates.
• Ability to comply with covenants in the credit agreement with Capital One.
• Changes in market conditions and receptivity to products and services.
• Ability to develop and release new products and services and successful enhancements.
• Maintaining the security and availability of the platform; impact of cyberattacks, security incidents, or breaches.
• Changes in laws and regulations applicable to the business model.
• Accuracy of predictions about the industry and addressable market.
• Ability to attract, retain, and cross-sell to healthcare services clients.
• Challenges in operating effectively with a primarily remote workforce and attracting/retaining key talent.
• Difficulties in realizing intended benefits of acquisitions and partnerships, and integrating acquisitions and investments.
• Impact of artificial intelligence, including security risks to confidential information, increased regulatory and compliance burden, and increased competition.
• General market, political, economic, and business conditions, including changes in U.S. presidential administration, tariff and trade issues, and warfare/political/economic instability in Ukraine, the Middle East, or elsewhere.
• Potential liabilities arising from "RK Matters" and "UCC Corrective Actions" as outlined in the merger agreement's indemnification provisions.

Future Outlook

Phreesia is maintaining its fiscal 2026 revenue outlook in the range of $472 million to $482 million, excluding any additional revenue from the AccessOne Acquisition. The Adjusted EBITDA outlook for fiscal 2026 has been updated to a range of $87 million to $92 million, up from the previous $85 million to $90 million, reflecting expected continued improvements in operating leverage and efficiency, also excluding the AccessOne Acquisition. The company expects AHSCs to reach approximately 4,500 and total revenue per AHSC to increase from fiscal 2025. Phreesia intends to update its fiscal 2026 financial outlook after the AccessOne Acquisition closes, which is expected in Q3 or early Q4 Fiscal 2026. The company believes its current cash balance of $98.3 million and cash generated from operations provide sufficient flexibility to meet its fiscal 2026 outlook, with additional borrowing capacity available under its credit facility for future growth opportunities.

Management Comments

• "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future." Chaim Indig, CEO and Co-Founder.
• "I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables." Chaim Indig, CEO and Co-Founder.
• "We have followed AccessOne's progress over many years and admired its approach to addressing a critical gap in care that is consistent with our mission of making care easier every day." Chaim Indig, CEO and Co-Founder.
• "When we began thinking of the right home for AccessOne, Phreesia consistently came up as a natural fit operationally, strategically and culturally." Mark Spinner, CEO of AccessOne.
• "We look forward to drawing on the resources of a larger organization with domain expertise, access to capital and a strong reputation among clients, employees and investors." Mark Spinner, CEO of AccessOne.
• "We look forward to continuing to support the KCC Model's success by activating patients in their care." Chaim Indig, CEO and Co-Founder.

Industry Context

The acquisition of AccessOne positions Phreesia to further capitalize on the growing trend of patient financial responsibility in healthcare. By integrating AccessOne's financing solutions for healthcare receivables, Phreesia is addressing a critical market need for providers to improve collections while maintaining patient trust, especially as out-of-pocket healthcare costs continue to rise. The expansion of its total addressable market by an estimated $6 billion through this acquisition, alongside the introduction of AI-powered solutions like VoiceAI and AI-Assisted Referrals, demonstrates Phreesia's commitment to leveraging technology to enhance operational efficiencies and patient engagement in the competitive healthcare IT and patient activation space. The collaboration with Sesame Workshop and continued involvement in the CMMI Kidney Care Choices Model also highlight a broader industry focus on patient education, preventive care, and chronic disease management.

Management Changes

Corporate Governance

Legal Proceedings

• The merger agreement states that no Order has been entered and not withdrawn, threatened in writing or is pending which would prevent the performance of this Agreement or the consummation of any of the transactions contemplated by this Agreement, declare unlawful the transactions contemplated by this Agreement or cause such transactions to be rescinded.
• The merger agreement identifies "RK Matters" and "UCC Corrective Actions" as "Indemnified Liabilities" or actions to be completed, indicating past or ongoing legal/compliance issues that required remediation or indemnification, which are being addressed as part of the transaction.

Related Party Transactions

• Restrictive covenant agreements were entered into by certain AccessOne equityholders, including management team members (Mark Spinner, Marina Bigsby, KaLynn Gates, Rajneesh Kumar, Raymond Morel), with effectiveness upon closing.
• Employment agreements were entered into by Mark Spinner, Marina Bigsby, KaLynn Gates, Rajneesh Kumar, and Raymond Morel with Acquiror, effective upon closing.
• The "Spinner Note" (Promissory Note from Mark Spinner) is mentioned as an item that could incur Taxes if not respected for Tax purposes as indebtedness, indicating a past related-party financial arrangement.

Stakeholder Impact

• Shareholders: Potential for increased share price due to strong financial performance and strategic acquisition; potential for future dilution from capital raises (bridge loan).
• Employees: New management titles for key personnel; restrictive covenants and employment agreements for AccessOne management; potential integration challenges or opportunities for employees of both companies.
• Customers: Expanded suite of payment solutions and new AI-powered products (VoiceAI, AI-Assisted Referrals, OON Tags) are expected to enhance patient experience, improve collections, and drive efficiency.
• Suppliers/Partners: Continued and new collaborations (e.g., Sesame Workshop, CMMI, COPD Foundation) indicate ongoing strategic relationships.
• Creditors: New bridge loan facility and existing credit facility with Capital One indicate ongoing debt financing.

Next Steps

• Close the AccessOne Acquisition during the third quarter or early fourth quarter of Phreesia's 2026 fiscal year, subject to customary closing conditions and regulatory approvals.
• Update fiscal 2026 financial outlook following the close of the AccessOne Acquisition.
• Launch joint campaigns with Sesame Workshop on Phreesia's digital intake platform in October 2025.
• Continue supporting the CMMI Kidney Care Choices Model through August 2026.
• Integrate AccessOne's platform and realize operational and corporate synergies.

Key Dates

Recommendation

Phreesia's Q2 Fiscal 2026 results demonstrate significant financial improvement, including achieving its first-ever net income positive quarter and a substantial increase in Adjusted EBITDA and free cash flow. The strategic acquisition of AccessOne is a highly positive development, expanding the company's addressable market by an estimated $6 billion and is expected to be accretive to both revenue and Adjusted EBITDA. The raised Adjusted EBITDA outlook for fiscal 2026 (excluding the acquisition) further underscores management's confidence in operational efficiency. These factors, combined with continued client growth and innovative product launches, position Phreesia for strong future performance and make it a compelling investment opportunity.

Keywords

Healthcare Technology, Patient Activation, Merger and Acquisition, Financial Results, Q2 Fiscal 2026, AccessOne, Healthcare Receivables, Payment Solutions, Adjusted EBITDA, Net Income, Free Cash Flow, AI in Healthcare, Corporate Growth, PHR Stock, Health Systems, Revenue Cycle Management